2017 MIPS Quality Measures

Quality IdMeasure NameHigh PriorityMeasure TypeDetailsMeasure DescriptionFull Specifications
093Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate UseYesProcess
Details
Percentage of patients aged 2 years and older with a diagnosis of AOE who were not prescribed systemic antimicrobial therapyRead More
091Acute Otitis Externa (AOE): Topical TherapyYesProcess
Details
Percentage of patients aged 2 years and older with a diagnosis of AOE who were prescribed topical preparationsRead More
383Adherence to Antipsychotic Medications For Individuals with SchizophreniaYesIntermediate Outcome
Details
Percentage of individuals at least 18 years of age as of the beginning of the measurement period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the measurement period (12 consecutive months)Read More
122Adult Kidney Disease: Blood Pressure ManagementYesIntermediate Outcome
Details
Percentage of patient visits for those patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (stage 3, 4, or 5, not receiving Renal Replacement Therapy [RRT]) with a blood pressure < 140/90 mmHg OR >= 140/90 mmHg with a documented plan of careRead More
329Adult Kidney Disease: Catheter Use at Initiation of HemodialysisYesOutcome
Details
Percentage of patients aged 18 years and older with a diagnosis of End Stage Renal Disease (ESRD) who initiate maintenance hemodialysis during the measurement period, whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiatedRead More
330Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 DaysYesOutcome
Details
Percentage of patients aged 18 years and older with a diagnosis of End Stage Renal Disease (ESRD) receiving maintenance hemodialysis for greater than or equal to 90 days whose mode of vascular access is a catheterRead More
403Adult Kidney Disease: Referral to HospiceYesProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of ESRD who withdraw from hemodialysis or peritoneal dialysis who are referred to hospice careRead More
325Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid ConditionsYesProcess
Details
Percentage of medical records of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) and a specific diagnosed comorbid condition (diabetes, coronary artery disease, ischemic stroke, intracranial hemorrhage, chronic kidney disease [stages 4 or 5], End Stage Renal Disease [ESRD] or congestive heart failure) being treated by another clinician with communication to the clinician treating the comorbid conditionRead More
384Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of SurgeryYesOutcome
Details
Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment who did not require a return to the operating room within 90 days of surgeryRead More
385Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of SurgeryYesOutcome
Details
Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eyeRead More
331Adult Sinusitis: Antibiotic Prescribed for Acute Sinusitis (Overuse)YesProcess
Details
Percentage of patients, aged 18 years and older, with a diagnosis of acute sinusitis who were prescribed an antibiotic within 10 days after onset of symptomsRead More
332Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)YesProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosisRead More
333Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse)YesEfficiency
Details
Percentage of patients aged 18 years and older, with a diagnosis of acute sinusitis who had a computerized tomography (CT) scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosisRead More
334Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse)YesEfficiency
Details
Percentage of patients aged 18 years and older with a diagnosis of chronic sinusitis who had more than one CT scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosisRead More
439Age Appropriate Screening ColonoscopyYesEfficiency
Details
The percentage of patients greater than 85 years of age who received a screening colonoscopy from January 1 to December 31Read More
140Age-Related Macular Degeneration (AMD): Counseling on Antioxidant SupplementNoProcess
Details
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formulation for preventing progression of AMDRead More
014Age-Related Macular Degeneration (AMD): Dilated Macular ExaminationNoProcess
Details
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or hemorrhage AND the level of macular degeneration severity during one or more office visits within 12 monthsRead More
458All-cause Hospital ReadmissionNoOutcome
Details
The 30-day All-Cause Hospital Readmission measure is a risk-standardized readmission rate for beneficiaries age 65 or older who were hospitalized at a short-stay acute care hospital and experienced an unplanned readmission for any cause to an acute care hospital within 30 days of discharge.Read More
386Amyotrophic Lateral Sclerosis (ALS) Patient Care PreferencesYesProcess
Details
Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g., advance directives, invasive ventilation, hospice) at least once annuallyRead More
354Anastomotic Leak InterventionYesOutcome
Details
Percentage of patients aged 18 years and older who required an anastomotic leak intervention following gastric bypass or colectomy surgeryRead More
404Anesthesiology Smoking AbstinenceYesIntermediate Outcome
Details
The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedureRead More
387Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug UsersNoProcess
Details
Percentage of patients, regardless of age, who are active injection drug users who received screening for HCV infection within the 12 month reporting periodRead More
421Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for RemovalNoProcess
Details
Percentage of patients in whom a retrievable IVC filter is placed who, within 3 months post-placement, have a documented assessment for the appropriateness of continued filtration, device removal or the inability to contact the patient with at least two attemptsRead More
405Appropriate Follow-up Imaging for Incidental Abdominal LesionsYesProcess
Details
Percentage of final reports for abdominal imaging studies for asymptomatic patients aged 18 years and older with one or more of the following noted incidentally with follow-up imaging recommended: Liver lesion <= 0.5 cm Cystic kidney lesion < 1.0 cm Adrenal lesion <= 1.0 cmRead More
406Appropriate Follow-up Imaging for Incidental Thyroid Nodules in PatientsYesProcess
Details
Percentage of final reports for computed tomography (CT), CT angiography (CTA) or magnetic resonance imaging (MRI) or magnetic resonance angiogram (MRA) studies of the chest or neck or ultrasound of the neck for patients aged 18 years and older with no known thyroid disease with a thyroid nodule < 1.0 cm noted incidentally with follow-up imaging recommendedRead More
320Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk PatientsYesProcess
Details
Percentage of patients aged 50 to 75 years of age receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy reportRead More
066Appropriate Testing for Children with PharyngitisYesProcess
Details
Percentage of children 3-18 years of age who were diagnosed with pharyngitis, ordered an antibiotic and received a group A streptococcus (strep) test for the episodeRead More
065Appropriate Treatment for Children with Upper Respiratory Infection (URI)YesProcess
Details
Percentage of children 3 months-18 years of age who were diagnosed with upper respiratory infection (URI) and were not dispensed an antibiotic prescription on or three days after the episodeRead More
407Appropriate Treatment of Methicillin-Sensitive Staphylococcus Aureus (MSSA) BacteremiaYesProcess
Details
Percentage of patients with sepsis due to MSSA bacteremia who received beta-lactam antibiotic (e.g. nafcillin, oxacillin or cefazolin) as definitive therapyRead More
448Appropriate Workup Prior to Endometrial AblationYesProcess
Details
Percentage of women, aged 18 years and older, who undergo endometrial sampling or hysteroscopy with biopsy before undergoing an endometrial ablationRead More
326Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of nonvalvular atrial fibrillation (AF) or atrial flutter whose assessment of the specified thromboembolic risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS2 risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolismRead More
116Avoidance of Antibiotic Treatment in Adults With Acute BronchitisYesProcess
Details
The percentage of adults 18-64 years of age with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescriptionRead More
249Barrett's EsophagusNoProcess
Details
Percentage of esophageal biopsy reports that document the presence of Barrett's mucosa that also include a statement about dysplasiaRead More
440Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time - Pathologist to ClinicianYesProcess
Details
Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) (including in situ disease) in which the pathologist communicates results to the clinician within 7 days of biopsy dateRead More
265Biopsy Follow-UpYesProcess
Details
Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient by the performing physicianRead More
099Breast Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic GradeNoProcess
Details
Percentage of breast cancer resection pathology reports that include the pT category (primary tumor), the pN category (regional lymph nodes), and the histologic gradeRead More
112Breast Cancer ScreeningNoProcess
Details
Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer.Read More
321CAHPS for PQRS Clinician/Group SurveyYesPatient Engagement/Experience
Details
Getting timely care, appointments, and information; How well providers Communicate; Patient's Rating of Provider; Access to Specialists; Health Promotion & Education; Shared Decision Making; Health Status/Functional Status; Courteous and Helpful Office Staff; Care Coordination; Between Visit Communication; Helping Your to Take Medication as Directed; and Stewardship of Patient ResourcesRead More
243Cardiac Rehabilitation Patient Referral from an Outpatient SettingYesProcess
Details
Percentage of patients evaluated in an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic stable angina (CSA) and have not already participated in an early outpatient cardiac rehabilitation/secondary prevention (CR) program for the qualifying event/diagnosis who were referred to a CR programRead More
322Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery PatientsYesEfficiency
Details
Percentage of stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), or cardiac magnetic resonance (CMR) performed in low risk surgery patients 18 years or older for preoperative evaluation during the 12-month reporting periodRead More
323Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)YesEfficiency
Details
Percentage of all stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), and cardiovascular magnetic resonance (CMR) performed in patients aged 18 years and older routinely after percutaneous coronary intervention (PCI), with reference to timing of test after PCI and symptom statusRead More
324Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk PatientsYesEfficiency
Details
Percentage of all stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), and cardiovascular magnetic resonance (CMR) performed in asymptomatic, low coronary heart disease (CHD) risk patients 18 years and older for initial detection and risk assessmentRead More
047Care PlanYesProcess
Details
Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker or provide an advance care planRead More
191Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract SurgeryYesOutcome
Details
Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved within 90 days following the cataract surgeryRead More
192Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical ProceduresYesOutcome
Details
Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and had any of a specified list of surgical procedures in the 30 days following cataract surgery which would indicate the occurrence of any of the following major complications: retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscenceRead More
303Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract SurgeryYesOutcome
Details
Percentage of patients aged 18 years and older who had cataract surgery and had improvement in visual function achieved within 90 days following the cataract surgery, based on completing a pre-operative and post-operative visual function surveyRead More
304Cataracts: Patient Satisfaction within 90 Days Following Cataract SurgeryYesOutcome
Details
Percentage of patients aged 18 years and older who had cataract surgery and were satisfied with their care within 90 days following the cataract surgery, based on completion of the Consumer Assessment of Healthcare Providers and Systems Surgical Care SurveyRead More
389Cataract Surgery: Difference Between Planned and Final RefractionYesOutcome
Details
Percentage of patients aged 18 years and older who had cataract surgery performed and who achieved a final refraction within +/- 0.5 diopters of their planned (target) refractionRead More
388Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule Requiring Unplanned Vitrectomy)YesOutcome
Details
Percentage of patients aged 18 years and older who had cataract surgery performed and had an unplanned rupture of the posterior capsule requiring vitrectomyRead More
447Chlamydia Screening and Follow UpNoProcess
Details
The percentage of female adolescents 16 years of age who had a chlamydia screening test with proper follow-up during the measurement periodRead More
052Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of COPD (FEV1/FVC < 70%) and who have an FEV1 less than 60% predicted and have symptoms who were prescribed an long-acting inhaled bronchodilatorRead More
051Chronic Obstructive Pulmonary Disease (COPD): Spirometry EvaluationNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of COPD who had spirometry results documentedRead More
409Clinical Outcome Post Endovascular Stroke TreatmentYesOutcome
Details
Percentage of patients with a mRs score of 0 to 2 at 90 days following endovascular stroke interventionRead More
185Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate UseYesProcess
Details
Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of a prior adenomatous polyp(s) in previous colonoscopy findings, which had an interval of 3 or more years since their last colonoscopyRead More
100Colorectal Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic GradeNoProcess
Details
Percentage of colon and rectum cancer resection pathology reports that include the pT category (primary tumor), the pN category (regional lymph nodes) and the histologic gradeRead More
113Colorectal Cancer ScreeningNoProcess
Details
Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer.Read More
024Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and OlderYesProcess
Details
Percentage of patients aged 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient's on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. This measure is reported by the physician who treats the fracture and who therefore is held accountable for the communicationRead More
236Controlling High Blood PressureYesIntermediate Outcome
Details
Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement periodRead More
165Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection RateYesOutcome
Details
Percentage of patients aged 18 years and older undergoing isolated CABG surgery who, within 30 days postoperatively, develop deep sternal wound infection involving muscle, bone, and/or mediastinum requiring operative interventionRead More
167Coronary Artery Bypass Graft (CABG): Postoperative Renal FailureYesOutcome
Details
Percentage of patients aged 18 years and older undergoing isolated CABG surgery (without pre-existing renal failure) who develop postoperative renal failure or require dialysisRead More
044Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG SurgeryNoProcess
Details
Percentage of isolated Coronary Artery Bypass Graft (CABG) surgeries for patients aged 18 years and older who received a beta-blocker within 24 hours prior to surgical incisionRead More
164Coronary Artery Bypass Graft (CABG): Prolonged IntubationYesOutcome
Details
Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation > 24 hoursRead More
166Coronary Artery Bypass Graft (CABG): StrokeYesOutcome
Details
Percentage of patients aged 18 years and older undergoing isolated CABG surgery who have a postoperative stroke (i.e., any confirmed neurological deficit of abrupt onset caused by a disturbance in blood supply to the brain) that did not resolve within 24 hoursRead More
168Coronary Artery Bypass Graft (CABG): Surgical Re-ExplorationYesOutcome
Details
Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require a return to the operating room (OR) during the current hospitalization for mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reasonRead More
043Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG SurgeryNoProcess
Details
Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graftRead More
118Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)NoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapyRead More
006Coronary Artery Disease (CAD): Antiplatelet TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12 month period who were prescribed aspirin or clopidogrelRead More
007Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)NoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior MI or a current or prior LVEF <40% who were prescribed beta-blocker therapyRead More
288Dementia: Caregiver Education and SupportYesProcess
Details
Percentage of patients, regardless of age, with a diagnosis of dementia whose caregiver(s) were provided with education on dementia disease management and health behavior changes AND referred to additional resources for support within a 12 month periodRead More
286Dementia: Counseling Regarding Safety ConcernsYesProcess
Details
Percentage of patients, regardless of age, with a diagnosis of dementia or their caregiver(s) who were counseled or referred for counseling regarding safety concerns within a 12 month periodRead More
282Dementia: Functional Status AssessmentNoProcess
Details
Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of functional status is performed and the results reviewed at least once within a 12 month periodRead More
284Dementia: Management of Neuropsychiatric SymptomsNoProcess
Details
Percentage of patients, regardless of age, with a diagnosis of dementia who have one or more neuropsychiatric symptoms who received or were recommended to receive an intervention for neuropsychiatric symptoms within a 12 month periodRead More
283Dementia: Neuropsychiatric Symptom AssessmentNoProcess
Details
Percentage of patients, regardless of age, with a diagnosis of dementia and for whom an assessment of neuropsychiatric symptoms is performed and results reviewed at least once in a 12 month periodRead More
411Depression Remission at Six MonthsYesOutcome
Details
Adult patients age 18 years and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at six months defined as a PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment. This measure additionally promotes ongoing contact between the patient and provider as patients who do not have a follow-up PHQ-9 score at six months (+/- 30 days) are also included in the denominatorRead More
370Depression Remission at Twelve MonthsYesOutcome
Details
Patients age 18 and older with major depression or dysthymia and an initial Patient Health Questionnaire (PHQ-9) score greater than nine who demonstrate remission at twelve months (+/- 30 days after an index visit) defined as a PHQ-9 score less than five. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment.Read More
117Diabetes: Eye ExamNoProcess
Details
Percentage of patients 18-75 years of age with diabetes who had a retinal or dilated eye exam by an eye care professional during the measurement period or a negative retinal exam (no evidence of retinopathy) in the 12 months prior to the measurement periodRead More
001Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)YesIntermediate Outcome
Details
Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement periodRead More
119Diabetes: Medical Attention for NephropathyNoProcess
Details
The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period.Read More
126Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological EvaluationNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 monthsRead More
127Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of FootwearNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizingRead More
019Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes CareYesProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 monthsRead More
130Documentation of Current Medications in the Medical RecordYesProcess
Details
Percentage of visits for patients aged 18 years and older for which the eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administration.Read More
412Documentation of Signed Opioid Treatment AgreementNoProcess
Details
All patients 18 and older prescribed opiates for longer than six weeks duration who signed an opioid treatment agreement at least once during Opioid Therapy documented in the medical record.Read More
413Door to Puncture Time for Endovascular Stroke TreatmentYesIntermediate Outcome
Details
Percentage of patients undergoing endovascular stroke treatment who have a door to puncture time of less than two hoursRead More
181Elder Maltreatment Screen and Follow-Up PlanYesProcess
Details
Percentage of patients aged 65 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening tool on the date of encounter AND a documented follow-up plan on the date of the positive screenRead More
415Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and OlderYesEfficiency
Details
Percentage of emergency department visits for patients aged 18 years and older who presented within 24 hours of a minor blunt head trauma with a Glasgow Coma Scale (GCS) score of 15 and who had a head CT for trauma ordered by an emergency care provider who have an indication for a head CTRead More
416Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 YearsYesEfficiency
Details
Percentage of emergency department visits for patients aged 2 through 17 years who presented within 24 hours of a minor blunt head trauma with a Glasgow Coma Scale (GCS) score of 15 and who had a head CT for trauma ordered by an emergency care provider who are classified as low risk according to the Pediatric Emergency Care Applied Research Network (PECARN) prediction rules for traumatic brain injuryRead More
268Epilepsy: Counseling for Women of Childbearing Potential with EpilepsyNoProcess
Details
All female patients of childbearing potential (12 - 44 years old) diagnosed with epilepsy who were counseled or referred for counseling for how epilepsy and its treatment may affect contraception OR pregnancy at least once a yearRead More
414Evaluation or Interview for Risk of Opioid MisuseNoProcess
Details
All patients 18 and older prescribed opiates for longer than six weeks duration evaluated for risk of opioid misuse using a brief validated instrument (e.g. Opioid Risk Tool, SOAPP-R) or patient interview documented at least once during Opioid Therapy in the medical recordRead More
155Falls: Plan of CareYesProcess
Details
Percentage of patients aged 65 years and older with a history of falls that had a plan of care for falls documented within 12 monthsRead More
154Falls: Risk AssessmentYesProcess
Details
Percentage of patients aged 65 years and older with a history of falls that had a risk assessment for falls completed within 12 monthsRead More
391Follow-Up After Hospitalization for Mental Illness (FUH)YesProcess
Details
The percentage of discharges for patients 6 years of age and older who were hospitalized for treatment of selected mental illness diagnoses and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner. Two rates are reported: The percentage of discharges for which the patient received follow-up within 30 days of discharge. The percentage of discharges for which the patient received follow-up within 7 days of dischargeRead More
182Functional Outcome AssessmentYesProcess
Details
Percentage of visits for patients aged 18 years and older with documentation of a current functional outcome assessment using a standardized functional outcome assessment tool on the date of the encounter AND documentation of a care plan based on identified functional outcome deficiencies on the date of the identified deficienciesRead More
222Functional Status Change for Patients with Elbow, Wrist or Hand ImpairmentsYesOutcome
Details
A self-report outcome measure of functional status (FS) for patients 14 years+ with elbow, wrist or hand impairments. The change in FS assessed using FOTO (elbow, wrist and hand) PROM (patient reported outcomes measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level to assess qualityRead More
219Functional Status Change for Patients with Foot or Ankle ImpairmentsYesOutcome
Details
A self-report measure of change in functional status (FS) for patients 14 years+ with foot and ankle impairments. The change in functional status (FS) assessed using FOTO's (foot and ankle) PROM (patient reported outcomes measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level to assess qualityRead More
223Functional Status Change for Patients with General Orthopaedic ImpairmentsYesOutcome
Details
A self-report outcome measure of functional status (FS) for patients 14 years+ with general orthopaedic impairments (neck, cranium, mandible, thoracic spine, ribs or other general orthopaedic impairment). The change in FS assessed using FOTO (general orthopaedic) PROM (patient reported outcomes measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level by to assess qualityRead More
218Functional Status Change for Patients with Hip ImpairmentsYesOutcome
Details
A self-report measure of change in functional status (FS) for patients 14 years+ with hip impairments. The change in functional status (FS) assessed using FOTO's (hip) PROM (patient- reported outcomes measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level to assess qualityRead More
217Functional Status Change for Patients with Knee ImpairmentsYesOutcome
Details
A self-report measure of change in functional status for patients 14 year+ with knee impairments. The change in functional status (FS) assessed using FOTO's (knee ) PROM (patient-reported outcomes measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level to assess qualityRead More
220Functional Status Change for Patients with Lumbar ImpairmentsYesOutcome
Details
A self-report outcome measure of change in functional status for patients 14 years+ with lumbar impairments. The change in functional status (FS) assessed using FOTO (lumbar) PROM (patient reported outcome measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level by to assess qualityRead More
221Functional Status Change for Patients with Shoulder ImpairmentsYesOutcome
Details
A self-report outcome measure of change in functional status (FS) for patients 14 years+ with shoulder impairments. The change in functional status (FS) assessed using FOTO's (shoulder) PROM (patient reported outcomes measure) is adjusted to patient characteristics known to be associated with FS outcomes (risk adjusted) and used as a performance measure at the patient level, at the individual clinician, and at the clinic level to assess qualityRead More
005Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)NoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital dischargeRead More
008Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)NoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital dischargeRead More
070Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow CytometryNoProcess
Details
Percentage of patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period who had baseline flow cytometry studies performed and documented in the chartRead More
069Hematology: Multiple Myeloma: Treatment with BisphosphonatesNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting periodRead More
067Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone MarrowNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrowRead More
068Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) who are receiving erythropoietin therapy with documentation of iron stores within 60 days prior to initiating erythropoietin therapyRead More
390Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment OptionsYesProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of hepatitis C with whom a physician or other qualified healthcare professional reviewed the range of treatment options appropriate to their genotype and demonstrated a shared decision making approach with the patient. To meet the measure, there must be documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatmentRead More
401Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with CirrhosisNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12 month reporting periodRead More
449HER2 Negative or Undocumented Breast Cancer Patients Spared Treatment with HER2-Targeted TherapiesYesProcess
Details
Proportion of female patients (aged 18 years and older) with breast cancer who are human epidermal growth factor receptor 2 (HER2)/neu negative who are not administered HER2-targeted therapiesRead More
205HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and SyphilisNoProcess
Details
Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS for whom chlamydia, gonorrhea, and syphilis screenings were performed at least once since the diagnosis of HIV infectionRead More
340HIV Medical Visit FrequencyYesProcess
Details
Percentage of patients, regardless of age with a diagnosis of HIV who had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visitsRead More
338HIV Viral Load SuppressionYesOutcome
Details
The percentage of patients, regardless of age, with a diagnosis of HIV with a HIV viral load less than 200 copies/mL at last HIV viral load test during the measurement yearRead More
392HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation AblationYesOutcome
Details
Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation This measure is reported as four rates stratified by age and gender: Reporting Age Criteria 1: Females 18-64years of age Reporting Age Criteria 2: Males 18-64 years of age Reporting Age Criteria 3: Females 65 years of age and older Reporting Age Criteria 4: Males 65 years of age and olderRead More
348HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications RateYesOutcome
Details
Patients with physician-specific risk-standardized rates of procedural complications following the first time implantation of an ICDRead More
393HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or RevisionYesOutcome
Details
Infection rate following CIED device implantation, replacement, or revisionRead More
262Image Confirmation of Successful Excision of Image-Localized Breast LesionYesProcess
Details
Image confirmation of lesion(s) targeted for image guided excisional biopsy or image guided partial mastectomy in patients with nonpalpable, image-detected breast lesion(s). Lesions may include: microcalcifications, mammographic or sonographic mass or architectural distortion, focal suspicious abnormalities on magnetic resonance imaging (MRI) or other breast imaging amenable to localization such as positron emission tomography (PET) mammography, or a biopsy marker demarcating site of confirmed pathology as established by previous core biopsyRead More
394Immunizations for AdolescentsNoProcess
Details
The percentage of adolescents 13 years of age who had the recommended immunizations by their 13th birthdayRead More
275Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted within one year prior to receiving a first course of anti-TNF (tumor necrosis factor) therapyRead More
271Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury - Bone Loss AssessmentNoProcess
Details
Percentage of patients aged 18 years and older with an inflammatory bowel disease encounter who were prescribed prednisone equivalents greater than or equal to 10 mg/day for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills and were documented for risk of bone loss once during the reporting year or the previous calendar yearRead More
441Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)YesIntermediate Outcome
Details
The IVD All-or-None Measure is one outcome measure (optimal control). The measure contains four goals. All four goals within a measure must be reached in order to meet that measure. The numerator for the all-or-none measure should be collected from the organization's total IVD denominator. All-or-None Outcome Measure (Optimal Control) - Using the IVD denominator optimal results include: Most recent blood pressure (BP) measurement is less than 140/90 mm Hg -- And Most recent tobacco status is Tobacco Free -- And Daily Aspirin or Other Antiplatelet Unless Contraindicated -- And Statin UseRead More
204Ischemic Vascular Disease (IVD): Use of Aspirin or Another AntiplateletNoProcess
Details
Percentage of patients 18 years of age and older who were diagnosed with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had documentation of use of aspirin or another antiplatelet during the measurement period.Read More
451KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody TherapyNoProcess
Details
Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom KRAS gene mutation testing was performedRead More
395Lung Cancer Reporting (Biopsy/Cytology Specimens)YesOutcome
Details
Pathology reports based on biopsy and/or cytology specimens with a diagnosis of primary non-small cell lung cancer classified into specific histologic type or classified as NSCLC-NOS with an explanation included in the pathology reportRead More
396Lung Cancer Reporting (Resection Specimens)YesOutcome
Details
Pathology reports based on resection specimens with a diagnosis of primary lung carcinoma that include the pT category, pN category and for non-small cell lung cancer, histologic typeRead More
335Maternity Care: Elective Delivery or Early Induction Without Medical Indication at >= 37 and < 39 Weeks (Overuse)YesOutcome
Details
Percentage of patients, regardless of age, who gave birth during a 12-month period who delivered a live singleton at >= 37 and < 39 weeks of gestation completed who had elective deliveries or early inductions without medical indicationRead More
336Maternity Care: Post-Partum Follow-Up and Care CoordinationYesProcess
Details
Percentage of patients, regardless of age, who gave birth during a 12-month period who were seen for post-partum care within 8 weeks of giving birth who received a breast feeding evaluation and education, post-partum depression screening, post-partum glucose screening for gestational diabetes patients, and family and contraceptive planningRead More
444Medication Management for People with AsthmaYesProcess
Details
The percentage of patients 5-64 years of age during the measurement year who were identified as having persistent asthma and were dispensed appropriate medications that they remained on for at least 75% of their treatment periodRead More
046Medication Reconciliation Post-DischargeYesProcess
Details
The percentage of discharges from any inpatient facility (e.g. hospital, skilled nursing facility, or rehabilitation facility) for patients 18 years and older of age seen within 30 days following discharge in the office by the physician, prescribing practitioner, registered nurse, or clinical pharmacist providing on-going care for whom the discharge medication list was reconciled with the current medication list in the outpatient medical record. This measure is reported as three rates stratified by age group: Reporting Criteria 1: 18-64 years of age Reporting Criteria 2: 65 years and older Total Rate: All patients 18 years of age and olderRead More
137Melanoma: Continuity of Care - Recall SystemYesStructure
Details
Percentage of patients, regardless of age, with a current diagnosis of melanoma or a history of melanoma whose information was entered, at least once within a 12 month period, into a recall system that includes: A target date for the next complete physical skin exam, AND A process to follow up with patients who either did not make an appointment within the specified timeframe or who missed a scheduled appointmentRead More
138Melanoma: Coordination of CareYesProcess
Details
Percentage of patient visits, regardless of age, with a new occurrence of melanoma who have a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosisRead More
224Melanoma: Overutilization of Imaging Studies in MelanomaYesProcess
Details
Percentage of patients, regardless of age, with a current diagnosis of Stage 0 through IIC melanoma or a history of melanoma of any stage, without signs or symptoms suggesting systemic spread, seen for an office visit during the one-year measurement period, for whom no diagnostic imaging studies were orderedRead More
397Melanoma ReportingYesOutcome
Details
Pathology reports for primary malignant cutaneous melanoma that include the pT category and a statement on thickness and ulceration and for pT1, mitotic rateRead More
443Non-Recommended Cervical Cancer Screening in Adolescent FemalesYesProcess
Details
The percentage of adolescent females 16-20 years of age who were screened unnecessarily for cervical cancerRead More
147Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone ScintigraphyYesProcess
Details
Percentage of final reports for all patients, regardless of age, undergoing bone scintigraphy that include physician documentation of correlation with existing relevant imaging studies (e.g., x-ray, MRI, CT, etc.) that were performedRead More
143Oncology: Medical and Radiation - Pain Intensity QuantifiedYesProcess
Details
Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantifiedRead More
144Oncology: Medical and Radiation - Plan of Care for PainYesProcess
Details
Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address painRead More
156Oncology: Radiation Dose Limits to Normal TissuesYesProcess
Details
Percentage of patients, regardless of age, with a diagnosis of breast, rectal, pancreatic or lung cancer receiving 3D conformal radiation therapy who had documentation in medical record that radiation dose limits to normal tissues were established prior to the initiation of a course of 3D conformal radiation for a minimum of two tissuesRead More
400One-Time Screening for Hepatitis C Virus (HCV) for Patients at RiskNoProcess
Details
Percentage of patients aged 18 years and older with one or more of the following: a history of injection drug use, receipt of a blood transfusion prior to 1992, receiving maintenance hemodialysis, OR birthdate in the years 1945-1965 who received one-time screening for hepatitis C virus (HCV) infectionRead More
446Operative Mortality Stratified by the Five STS-EACTS Mortality CategoriesYesOutcome
Details
Percent of patients undergoing index pediatric and/or congenital heart surgery who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days (including patients transferred to other acute care facilities), and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure, stratified by the five STAT Mortality Levels, a multi-institutional validated complexity stratification toolRead More
408Opioid Therapy Follow-up EvaluationNoProcess
Details
All patients 18 and older prescribed opiates for longer than six weeks duration who had a follow-up evaluation conducted at least every three months during Opioid Therapy documented in the medical recordRead More
398Optimal Asthma ControlYesOutcome
Details
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbationRead More
364Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended GuidelinesYesProcess
Details
Percentage of final reports for computed tomography (CT) imaging studies of the thorax for patients aged 18 years and older with documented follow-up recommendations for incidentally detected pulmonary nodules (e.g., follow-up CT imaging studies needed or that no follow-up is needed) based at a minimum on nodule size AND patient risk factorsRead More
362Optimizing Patient Exposure to Ionizing Radiation: Computed Tomography (CT) Images Available for Patient Follow-up and Comparison PurposesYesStructure
Details
Percentage of final reports for computed tomography (CT) studies performed for all patients, regardless of age, which document that Digital Imaging and Communications in Medicine (DICOM) format image data are available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the studyRead More
360Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine StudiesYesProcess
Details
Percentage of computed tomography (CT) and cardiac nuclear medicine (myocardial perfusion studies) imaging reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion) studies that the patient has received in the 12-month period prior to the current studyRead More
361Optimizing Patient Exposure to Ionizing Radiation: Reporting to a Radiation Dose Index RegistryYesStructure
Details
Percentage of total computed tomography (CT) studies performed for all patients, regardless of age, that are reported to a radiation dose index registry that is capable of collecting at a minimum selected data elementsRead More
363Optimizing Patient Exposure to Ionizing Radiation: Search for Prior Computed Tomography (CT) Studies Through a Secure, Authorized, Media-Free, Shared ArchiveYesStructure
Details
Percentage of final reports of computed tomography (CT) studies performed for all patients, regardless of age, which document that a search for Digital Imaging and Communications in Medicine (DICOM) format images was conducted for prior patient CT imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performedRead More
359Optimizing Patient Exposure to Ionizing Radiation: Utilization of a Standardized Nomenclature for Computed Tomography (CT) Imaging DescriptionYesProcess
Details
Percentage of computed tomography (CT) imaging reports for all patients, regardless of age, with the imaging study named according to a standardized nomenclature and the standardized nomenclature is used in institution's computer systemsRead More
109Osteoarthritis (OA): Function and Pain AssessmentYesProcess
Details
Percentage of patient visits for patients aged 21 years and older with a diagnosis of osteoarthritis (OA) with assessment for function and painRead More
418Osteoporosis Management in Women Who Had a FractureNoProcess
Details
The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis in the six months after the fractureRead More
419Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological ExaminationYesEfficiency
Details
Percentage of patients with a diagnosis of primary headache disorder whom advanced brain imaging was not orderedRead More
131Pain Assessment and Follow-UpYesProcess
Details
Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is presentRead More
342Pain Brought Under Control Within 48 HoursYesOutcome
Details
Patients aged 18 and older who report being uncomfortable because of pain at the initial assessment (after admission to palliative care services) that report pain was brought to a comfortable level within 48 hoursRead More
291Parkinson's Disease: Cognitive Impairment or Dysfunction AssessmentNoProcess
Details
All patients with a diagnosis of Parkinson's disease who were assessed for cognitive impairment or dysfunction in the last 12 monthsRead More
294Parkinson's Disease: Parkinson's Disease Medical and Surgical Treatment Options ReviewedYesProcess
Details
All patients with a diagnosis of Parkinson's disease (or caregiver(s), as appropriate) who had the Parkinson's disease treatment options (e.g., non-pharmacological treatment, pharmacological treatment, or surgical treatment) reviewed at least annuallyRead More
290Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's DiseaseNoProcess
Details
All patients with a diagnosis of Parkinson's disease who were assessed for psychiatric symptoms (e.g., psychosis, depression, anxiety disorder, apathy, or impulse control disorder) in the last 12 monthsRead More
293Parkinson's Disease: Rehabilitative Therapy OptionsYesProcess
Details
All patients with a diagnosis of Parkinson's Disease (or caregiver(s), as appropriate) who had rehabilitative therapy options (e.g., physical, occupational, or speech therapy) discussed in the last 12 monthsRead More
358Patient-Centered Surgical Risk Assessment and CommunicationYesProcess
Details
Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeonRead More
452Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal AntibodiesYesProcess
Details
Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer and KRAS gene mutation spared treatment with anti-EGFR monoclonal antibodiesRead More
327Pediatric Kidney Disease: Adequacy of Volume ManagementYesProcess
Details
Percentage of calendar months within a 12-month period during which patients aged 17 years and younger with a diagnosis of End Stage Renal Disease (ESRD) undergoing maintenance hemodialysis in an outpatient dialysis facility have an assessment of the adequacy of volume management from a nephrologistRead More
328Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/dLYesIntermediate Outcome
Details
Percentage of calendar months within a 12-month period during which patients aged 17 years and younger with a diagnosis of End Stage Renal Disease (ESRD) receiving hemodialysis or peritoneal dialysis have a hemoglobin level < 10 g/dLRead More
428Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary IncontinenceNoProcess
Details
Percentage of patients undergoing appropriate preoperative evaluation of stress urinary incontinence prior to pelvic organ prolapse surgery per ACOG/AUGS/AUA guidelinesRead More
429Pelvic Organ Prolapse: Preoperative Screening for Uterine MalignancyYesProcess
Details
Percentage of patients who are screened for uterine malignancy prior to vaginal closure or obliterative surgery for pelvic organ prolapseRead More
422Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract InjuryYesProcess
Details
Percentage of patients who undergo cystoscopy to evaluate for lower urinary tract injury at the time of hysterectomy for pelvic organ prolapseRead More
423Perioperative Anti-platelet Therapy for Patients Undergoing Carotid EndarterectomyNoProcess
Details
Percentage of patients undergoing carotid endarterectomy (CEA) who are taking an anti-platelet agent within 48 hours prior to surgery and are prescribed this medication at hospital discharge following surgeryRead More
021Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation CephalosporinYesProcess
Details
Percentage of surgical patients aged 18 years and older undergoing procedures with the indications for a first OR second generation cephalosporin prophylactic antibiotic who had an order for a first OR second generation cephalosporin for antimicrobial prophylaxisRead More
023Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)YesProcess
Details
Percentage of surgical patients aged 18 years and older undergoing procedures for which venous thromboembolism (VTE) prophylaxis is indicated in all patients, who had an order for Low Molecular Weight Heparin (LMWH), Low- Dose Unfractionated Heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end timeRead More
424Perioperative Temperature ManagementYesOutcome
Details
Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) was recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end timeRead More
442Persistence of Beta-Blocker Treatment After a Heart AttackNoProcess
Details
The percentage of patients 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who were prescribed persistent beta-blocker treatment for six months after dischargeRead More
425Photodocumentation of Cecal IntubationNoProcess
Details
The rate of screening and surveillance colonoscopies for which photodocumentation of landmarks of cecal intubation is performed to establish a complete examinationRead More
111Pneumococcal Vaccination Status for Older AdultsNoProcess
Details
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine.Read More
426Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU)YesProcess
Details
Percentage of patients, regardless of age, who are under the care of an anesthesia practitioner and are admitted to a PACU in which a post-anesthetic formal transfer of care protocol or checklist which includes the key transfer of care elements is utilizedRead More
427Post-Anesthetic Transfer of Care: Use of Checklist or Protocol for Direct Transfer of Care from Procedure Room to Intensive Care Unit (ICU)YesProcess
Details
Percentage of patients, regardless of age, who undergo a procedure under anesthesia and are admitted to an Intensive Care Unit (ICU) directly from the anesthetizing location, who have a documented use of a checklist or protocol for the transfer of care from the responsible anesthesia practitioner to the responsible ICU team or team memberRead More
263Preoperative Diagnosis of Breast CancerNoProcess
Details
The percent of patients undergoing breast cancer operations who obtained the diagnosis of breast cancer preoperatively by a minimally invasive biopsy methodRead More
076Prevention of Central Venous Catheter (CVC) - Related Bloodstream InfectionsYesProcess
Details
Percentage of patients, regardless of age, who undergo central venous catheter (CVC) insertion for whom CVC was inserted with all elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followedRead More
430Prevention of Post-Operative Nausea and Vomiting (PONV) - Combination TherapyYesProcess
Details
Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two prophylactic pharmacologic antiemetic agents of different classes preoperatively or intraoperativelyRead More
128Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up PlanNoProcess
Details
Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous six months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous six months of the current encounter Normal Parameters: Age 18 years and older BMI => 18.5 and < 25 kg/m2Read More
110Preventive Care and Screening: Influenza ImmunizationNoProcess
Details
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunizationRead More
134Preventive Care and Screening: Screening for Clinical Depression and Follow-Up PlanNoProcess
Details
Percentage of patients aged 12 years and older screened for depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screenRead More
317Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up DocumentedNoProcess
Details
Percentage of patients aged 18 years and older seen during the reporting period who were screened for high blood pressure AND a recommended follow-up plan is documented based on the current blood pressure (BP) reading as indicatedRead More
226Preventive Care and Screening: Tobacco Use: Screening and Cessation InterventionNoProcess
Details
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco userRead More
431Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief CounselingNoProcess
Details
Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol userRead More
012Primary Open-Angle Glaucoma (POAG): Optic Nerve EvaluationNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more office visits within 12 monthsRead More
141Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of CareYesOutcome
Details
Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 15% from the pre-intervention level) OR if the most recent IOP was not reduced by at least 15% from the pre-intervention level, a plan of care was documented within 12 monthsRead More
457Proportion Admitted to Hospice for less than 3 daysYesOutcome
Details
Proportion of patients who died from cancer, and admitted to hospice and spent less than 3 days thereRead More
455Proportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of LifeYesOutcome
Details
Proportion of patients who died from cancer admitted to the ICU in the last 30 days of lifeRead More
456Proportion Not Admitted To HospiceYesProcess
Details
Proportion of patients who died from cancer not admitted to hospiceRead More
432Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse RepairYesOutcome
Details
Percentage of patients undergoing any surgery to repair pelvic organ prolapse who sustains an injury to the bladder recognized either during or within 1 month after surgeryRead More
433Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse RepairYesOutcome
Details
Percentage of patients undergoing surgical repair of pelvic organ prolapse that is complicated by a bowel injury at the time of index surgery that is recognized intraoperatively or within 1 month after surgeryRead More
434Proportion of Patients Sustaining a Ureter Injury at the Time of any Pelvic Organ Prolapse RepairYesOutcome
Details
Percentage of patients undergoing pelvic organ prolapse repairs who sustain an injury to the ureter recognized either during or within 1 month after surgeryRead More
454Proportion of Patients who Died from Cancer with more than One Emergency Department Visit in the Last 30 Days of LifeYesOutcome
Details
Proportion of patients who died from cancer with more than one emergency department visit in the last 30 days of lifeRead More
453Proportion Receiving Chemotherapy in the Last 14 Days of LifeYesProcess
Details
Proportion of patients who died from cancer receiving chemotherapy in the last 14 days of lifeRead More
104Prostate Cancer: Adjuvant Hormonal Therapy for High Risk or Very High Risk Prostate CancerNoProcess
Details
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH [gonadotropin-releasing hormone] agonist or antagonist)Read More
102Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer PatientsYesProcess
Details
Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancerRead More
410Psoriasis: Clinical Response to Oral Systemic or Biologic MedicationsYesOutcome
Details
Percentage of psoriasis patients receiving oral systemic or biologic therapy who meet minimal physician-or patient- reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatmentRead More
435Quality of Life Assessment For Patients With Primary Headache DisordersYesOutcome
Details
Percentage of patients with a diagnosis of primary headache disorder whose health related quality of life (HRQoL) was assessed with a tool(s) during at least two visits during the 12 month measurement period AND whose health related quality of life score stayed the same or improvedRead More
251Quantitative Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) for Breast Cancer PatientsNoStructure
Details
This is a measure based on whether quantitative evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) by immunohistochemistry (IHC) uses the system recommended in the current ASCO/CAP Guidelines for Human Epidermal Growth Factor Receptor 2 Testing in breast cancerRead More
436Radiation Consideration for Adult CT: Utilization of Dose Lowering TechniquesNoProcess
Details
Percentage of final reports for patients aged 18 years and older undergoing CT with documentation that one or more of the following dose reduction techniques were used: Automated exposure control Adjustment of the mA and/or kV according to patient size Use of iterative reconstruction techniqueRead More
250Radical Prostatectomy Pathology ReportingNoProcess
Details
Percentage of radical prostatectomy pathology reports that include the pT category, the pN category, the Gleason score and a statement about margin statusRead More
145Radiology: Exposure Dose or Time Reported for Procedures Using FluoroscopyYesProcess
Details
Final reports for procedures using fluoroscopy that document radiation exposure indices, or exposure time and number of fluorographic images (if radiation exposure indices are not available)Read More
146Radiology: Inappropriate Use of Probably Benign" Assessment Category in Screening Mammograms"YesProcess
Details
Percentage of final reports for screening mammograms that are classified as probably benign""Read More
225Radiology: Reminder System for Screening MammogramsYesStructure
Details
Percentage of patients undergoing a screening mammogram whose information is entered into a reminder system with a target due date for the next mammogramRead More
195Radiology: Stenosis Measurement in Carotid Imaging ReportsNoProcess
Details
Percentage of final reports for carotid imaging studies (neck magnetic resonance angiography [MRA], neck computed tomography angiography [CTA], neck duplex ultrasound, carotid angiogram) performed that include direct or indirect reference to measurements of distal internal carotid diameter as the denominator for stenosis measurementRead More
344Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)YesOutcome
Details
Percent of asymptomatic patients undergoing CAS who are discharged to home no later than post-operative day #2Read More
260Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)YesOutcome
Details
Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2Read More
347Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) Who Die While in HospitalYesOutcome
Details
Percent of patients undergoing endovascular repair of small or moderate infrarenal abdominal aortic aneurysms (AAA) that die while in the hospitalRead More
259Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2)YesOutcome
Details
Percent of patients undergoing endovascular repair of small or moderate non-ruptured infrarenal abdominal aortic aneurysms (AAA) that do not experience a major complication (discharged to home no later than post-operative day #2)Read More
417Rate of Open Repair of Small or Moderate Abdominal Aortic Aneurysms (AAA) Where Patients Are Discharged AliveYesOutcome
Details
Percentage of patients undergoing open repair of small or moderate abdominal aortic aneurysms (AAA) who are discharged aliveRead More
258Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7)YesOutcome
Details
Percent of patients undergoing open repair of small or moderate sized non-ruptured infrarenal abdominal aortic aneurysms who do not experience a major complication (discharge to home no later than post-operative day #7)Read More
345Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS)YesOutcome
Details
Percent of asymptomatic patients undergoing CAS who experience stroke or death following surgery while in the hospitalRead More
346Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Endarterectomy (CEA)YesOutcome
Details
Percent of asymptomatic patients undergoing CEA who experience stroke or death following surgery while in the hospitalRead More
437Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization ProcedureYesOutcome
Details
Inpatients assigned to endovascular treatment for obstructive arterial disease, the percent of patients who undergo unplanned major amputation or surgical bypass within 48 hours of the index procedureRead More
261Referral for Otologic Evaluation for Patients with Acute or Chronic DizzinessYesProcess
Details
Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizzinessRead More
179Rheumatoid Arthritis (RA): Assessment and Classification of Disease PrognosisNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 monthsRead More
178Rheumatoid Arthritis (RA): Functional Status AssessmentNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 monthsRead More
180Rheumatoid Arthritis (RA): Glucocorticoid ManagementNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >= 10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid management plan within 12 monthsRead More
177Rheumatoid Arthritis (RA): Periodic Assessment of Disease ActivityNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease activity within 12 monthsRead More
176Rheumatoid Arthritis (RA): Tuberculosis ScreeningNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have documentation of a tuberculosis (TB) screening performed and results interpreted within 6 months prior to receiving a first course of therapy using a biologic disease-modifying anti-rheumatic drug (DMARD)Read More
255Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood ExposureNoProcess
Details
Percentage of Rh-negative pregnant women aged 14-50 years at risk of fetal blood exposure who receive Rh- Immunoglobulin (Rhogam) in the emergency department (ED)Read More
445Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)YesOutcome
Details
Percent of patients aged 18 years and older undergoing isolated CABG who die, including both all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedureRead More
343Screening Colonoscopy Adenoma Detection RateYesOutcome
Details
The percentage of patients age 50 years or older with at least one conventional adenoma or colorectal cancer detected during screening colonoscopyRead More
039Screening for Osteoporosis for Women Aged 65-85 Years of AgeNoProcess
Details
Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosisRead More
264Sentinel Lymph Node Biopsy for Invasive Breast CancerNoProcess
Details
The percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients who undergo a sentinel lymph node (SLN) procedureRead More
279Sleep Apnea: Assessment of Adherence to Positive Airway Pressure TherapyNoProcess
Details
Percentage of visits for patients aged 18 years and older with a diagnosis of obstructive sleep apnea who were prescribed positive airway pressure therapy who had documentation that adherence to positive airway pressure therapy was objectively measuredRead More
276Sleep Apnea: Assessment of Sleep SymptomsNoProcess
Details
Percentage of visits for patients aged 18 years and older with a diagnosis of obstructive sleep apnea that includes documentation of an assessment of sleep symptoms, including presence or absence of snoring and daytime sleepinessRead More
278Sleep Apnea: Positive Airway Pressure Therapy PrescribedNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of moderate or severe obstructive sleep apnea who were prescribed positive airway pressure therapyRead More
277Sleep Apnea: Severity Assessment at Initial DiagnosisNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea who had an apnea hypopnea index (AHI) or a respiratory disturbance index (RDI) measured at the time of initial diagnosisRead More
257Statin Therapy at Discharge after Lower Extremity Bypass (LEB)NoProcess
Details
Percentage of patients aged 18 years and older undergoing infra-inguinal lower extremity bypass who are prescribed a statin medication at dischargeRead More
438Statin Therapy for the Prevention and Treatment of Cardiovascular DiseaseNoProcess
Details
Percentage of the following patients-all considered at high risk of cardiovascular events-who were prescribed or were on statin therapy during the measurement period: Adults aged >= 21 years who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD); OR Adults aged >=21 years who have ever had a fasting or direct low-density lipoprotein cholesterol (LDL-C) level >= 190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial or pure hypercholesterolemia; OR Adults aged 40-75 years with a diagnosis of diabetes with a fasting or direct LDL-C level of 70-189 mg/dLRead More
032Stroke and Stroke Rehabilitation: Discharged on Antithrombotic TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) who were prescribed antithrombotic therapy at dischargeRead More
187Stroke and Stroke Rehabilitation: Thrombolytic TherapyNoProcess
Details
Percentage of patients aged 18 years and older with a diagnosis of acute ischemic stroke who arrive at the hospital within two hours of time last known well and for whom IV t-PA was initiated within three hours of time last known wellRead More
357Surgical Site Infection (SSI)YesOutcome
Details
Percentage of patients aged 18 years and older who had a surgical site infection (SSI)Read More
402Tobacco Use and Help with Quitting Among AdolescentsNoProcess
Details
The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco userRead More
353Total Knee Replacement: Identification of Implanted Prosthesis in Operative ReportYesProcess
Details
Percentage of patients regardless of age undergoing a total knee replacement whose operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implantRead More
352Total Knee Replacement: Preoperative Antibiotic Infusion with Proximal TourniquetYesProcess
Details
Percentage of patients regardless of age undergoing a total knee replacement who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquetRead More
350Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) TherapyYesProcess
Details
Percentage of patients regardless of age undergoing a total knee replacement with documented shared decision-making with discussion of conservative (non-surgical) therapy (e.g., non-steroidal anti-inflammatory drug (NSAIDs), analgesics, weight loss, exercise, injections) prior to the procedureRead More
351Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk EvaluationYesProcess
Details
Percentage of patients regardless of age undergoing a total knee replacement who are evaluated for the presence or absence of venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction (MI), Arrhythmia and Stroke)Read More
450Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant ChemotherapyYesProcess
Details
Proportion of female patients (aged 18 years and older) with AJCC stage I (T1c) - III, human epidermal growth factor receptor 2 (HER2) positive breast cancer receiving adjuvant chemotherapy who are also receiving trastuzumabRead More
337Tuberculosis (TB) Prevention for Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response ModifierNoProcess
Details
Percentage of patients whose providers are ensuring active tuberculosis prevention either through yearly negative standard tuberculosis screening tests or are reviewing the patient's history to determine if they have had appropriate management for a recent or prior positive testRead More
254Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal PainNoProcess
Details
Percentage of pregnant female patients aged 14 to 50 who present to the emergency department (ED) with a chief complaint of abdominal pain or vaginal bleeding who receive a trans-abdominal or trans-vaginal ultrasound to determine pregnancy locationRead More
356Unplanned Hospital Readmission within 30 Days of Principal ProcedureYesOutcome
Details
Percentage of patients aged 18 years and older who had an unplanned hospital readmission within 30 days of principal procedureRead More
355Unplanned Reoperation within the 30 Day Postoperative PeriodYesOutcome
Details
Percentage of patients aged 18 years and older who had any unplanned reoperation within the 30 day postoperative periodRead More
048Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and OlderNoProcess
Details
Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence within 12 monthsRead More
050Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and OlderYesProcess
Details
Percentage of female patients aged 65 years and older with a diagnosis of urinary incontinence with a documented plan of care for urinary incontinence at least once within 12 monthsRead More
238Use of High-Risk Medications in the ElderlyYesProcess
Details
Percentage of patients 66 years of age and older who were ordered high-risk medications. Two rates are reported. a. Percentage of patients who were ordered at least one high-risk medication. b. Percentage of patients who were ordered at least two different high-risk medications.Read More
420Varicose Vein Treatment with Saphenous Ablation: Outcome SurveyNoOutcome
Details
Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after treatmentRead More